Literature DB >> 33469546

Do Ocular Fluids Represent a Transmission Route of SARS-CoV-2 Infection?

Giulio Petronio Petronio1, Roberto Di Marco1, Ciro Costagliola1.   

Abstract

The spread of the new SARS-CoV-2 is marked by a short timeline. In this scenario, explaining or excluding the possible transmission routes is mandatory to contain and manage the spread of the disease in the community. In the recent pandemic, it is still unclear how coronavirus can end up in ocular fluids. Nevertheless, eye redness and irritation in COVID-19 patients have been reported, suggesting that a possible ocular manifestation of SARS-CoV-2 infection may be conjunctivitis. On the basis of epidemiological data provided by previous SARS-Cove infection, numerous theories have been proposed: (1) conjunctiva as the site of direct inoculation by infected droplets; (2) the nasolacrimal duct as a migration route of the virus to the upper respiratory tract, or (3) haematogenic infection of the tear gland. The demand for further investigations to verify ocular involvement in COVID-19 infection came out from the results of recent meta-analysis studies, so the eye cannot be completely excluded as a transmission route of the infection. Thus, healthcare personnel and all the people that enter in contact with infected or suspected patients must always use the prescribed protective equipment.
Copyright © 2021 Petronio Petronio, Di Marco and Costagliola.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; healthcare protection; ocular fluids; transmission route

Year:  2021        PMID: 33469546      PMCID: PMC7813776          DOI: 10.3389/fmed.2020.620412

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  5 in total

Review 1.  A Systematic Literature Review and Bibliometric Analysis of Ophthalmology and COVID-19 Research.

Authors:  Ali Forouhari; Vahid Mansouri; Sare Safi; Hamid Ahmadieh; Amir Ghaffari Jolfayi
Journal:  J Ophthalmol       Date:  2022-05-24       Impact factor: 1.974

2.  Ocular Surface Infection by SARS-CoV-2 in COVID-19 Pneumonia Patients Admitted to Sub-Intensive Unit: Preliminary Results.

Authors:  Mario Troisi; Carla Zannella; Salvatore Troisi; Maddalena De Bernardo; Massimiliano Galdiero; Gianluigi Franci; Nicola Rosa
Journal:  Microorganisms       Date:  2022-02-02

3.  Optical Coherence Tomography Angiography Analysis of Vessel Density Indices in Early Post-COVID-19 Patients.

Authors:  Flavia Chiosi; Giuseppe Campagna; Michele Rinaldi; Gianluigi Manzi; Roberto dell'Omo; Giuseppe Fiorentino; Mario Toro; Fausto Tranfa; Luca D'Andrea; Magdalena Rejdak; Ciro Costagliola
Journal:  Front Med (Lausanne)       Date:  2022-06-28

Review 4.  Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation.

Authors:  Giorgio Zauli; Sara AlHilali; Samar Al-Swailem; Paola Secchiero; Rebecca Voltan
Journal:  Front Med (Lausanne)       Date:  2022-07-14

5.  Ocular Involvement of SARS-CoV-2 in a Polish Cohort of COVID-19-Positive Patients.

Authors:  Joanna Dolar-Szczasny; Mario D Toro; Anna Dworzańska; Tomasz Wójtowicz; Izabela Korona-Glowniak; Rafał Sawicki; Anastazja Boguszewska; Małgorzata Polz-Dacewicz; Krzysztof Tomasiewicz; Wojciech Załuska; Robert Rejdak; Paola Bagnoli; Dario Rusciano
Journal:  Int J Environ Res Public Health       Date:  2021-03-12       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.